ClinicalTrials.Veeva

Menu

Sarcopenia and Physical Activity Intervention: a Randomized-controlled Trial

S

Scientific Institute San Raffaele

Status

Enrolling

Conditions

Sarcopenia

Treatments

Behavioral: Home-based physical activity

Study type

Interventional

Funder types

Other

Identifiers

NCT05071040
RF-2019-12370198

Details and patient eligibility

About

Sarcopenia is a pathophysiological process associated with aging and some metabolic conditions characterized by progressive muscle tissue loss, which may lead to loss of strength and performance and increased risk of falls and fractures, physical disability and premature death. With the present project the investigator aim to assess the effect of a feasible exercise program to improve muscle strength (primary outcome), and muscle volume and performance and other measures potentially associated with sarcopenia (secondary outcomes) in elderly and people living with HIV (PLWH) with sarcopenia. The investigators plan to enroll 98 elderly and 98 PLWH in a multicentric, 48-week, randomized, parallel-group, open label, superiority trial comparing the effect of a home-based and app-monitored strength exercise intervention versus no intervention. The investigators expect that participants who exercise will improve strength and other parameters and that improvement at week 12 and week 48 will be higher than in no-exercise controls.

Enrollment

198 estimated patients

Sex

All

Ages

50 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Sedentary
  • >60 year-old in the elderly group or >50 year-old for the PLWH group;
  • with sarcopenia, as defined by both relative loss of muscle mass by bioimpedentiometry (BIA) and low muscle strength by handgrip

Exclusion criteria

  • Any disease requiring hospitalization in the 6 weeks before enrollment;
  • Medical conditions contraindicating the proposed exercise as established by a sport medicine specialist;
  • Current substance or alcohol abuse or use of drugs that may influence balance and coordination;
  • Not being able to walk without assistance and to perform the prescribed exercises as by protocol.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

198 participants in 2 patient groups

Exercise group
Experimental group
Description:
Participants will follow a strength exercise program monitored through the use of a specifically designed smartphone application.
Treatment:
Behavioral: Home-based physical activity
Control group
No Intervention group
Description:
Continue their daily routine without exercise prescription.

Trial contacts and locations

1

Loading...

Central trial contact

Paola Cinque, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems